Citadel Advisors
GMOV

Citadel Advisors’s GMO US Value ETF GMOV Stock Holding History

Citadel Advisors’s Portfolio GMOV Stock Details GMOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,647
Closed -$327K – 15166
2026
Q1 		$327K Buy
+11,647
New +$332K ﹤0.01% 10287
2025
Q4 		– Sell
-30,075
Closed -$795K – 14464
2025
Q3 		$795K Buy
30,075
+20,913
+228% +$542K ﹤0.01% 8043
2025
Q2 		$232K Buy
+9,162
New +$219K ﹤0.01% 10382
2025
Q1 		– Sell
-29,956
Closed -$732K – 15859
2024
Q4 		$732K Buy
+29,956
New +$757K ﹤0.01% 7708

Other funds holding GMOV

CA
Commerce Advisors Memphis, Tennessee $184M AUM
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
LCWP
Legacy Capital Wealth Partners Little Rock, Arkansas $521M AUM 28.27% 1-Year Est. Return
FEG
Fund Evaluation Group Cincinnati, Ohio $3.7B AUM 16.56% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $217M AUM 47.35% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Citadel Advisors's GMOV Position: Q2 2026 in Review

Citadel Advisors sold out of GMO US Value ETF (GMOV) in Q2 2026, closing a stake of 11,647 shares — an estimated $327K sold.

Citadel Advisors first reported a position in GMOV in Q4 2024 and held it in 4 quarters. The position peaked at $795K in Q3 2025. 19 funds tracked by Wall St. Rank hold GMOV as of Q2 2026.

  • Citadel Advisors reported no remaining GMO US Value ETF position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 11,647 GMO US Value ETF shares in Q2 2026, an estimated $327K.
  • Citadel Advisors first reported a position in GMO US Value ETF in Q4 2024 and held it in 4 quarters.
  • Citadel Advisors's GMO US Value ETF position peaked at $795K in Q3 2025.
  • 19 funds tracked by Wall St. Rank held GMO US Value ETF as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.